Key result
Captopril treatment abolished the increase in plasma aldosterone concentration in response to potassium infusion, an effect that was restored by concurrent administration of angiotensin II.
Why the study?
Does angiotensin II mediate potassium-stimulated aldosterone secretion in dogs?
Does angiotensin II mediate potassium-stimulated aldosterone secretion in dogs?
Angiotensin II is essential for potassium-mediated stimulation of aldosterone secretion in dogs, highlighting a critical interdependence of these stimuli.
Answers are grounded in this paper and cite their sources.
Should not alter clinical aldosterone management; leaves open angiotensin II-potassium interdependence for human translation.
Potassium is known to enhance the aldosterone-stimulating action of angiotensin II. Such a synergistic interaction of potassium with angiotensin II could represent an action by angiotensin II to potentiate potassium as a stimulus. To examine for this effect of angiotensin II on potassium, plasma aldosterone levels were measured before and after an infusion of potassium chloride (15 meq i.v.) into dogs without and with prevention of angiotensin II formation by captopril, an angiotensin converting-enzyme inhibitor. In addition, responses to potassium were measured in a group of dogs receiving angiotensin II plus captopril. After potassium infusion, control dogs showed an increase of 7.7 +/- 1.9 (SEM) ng/dl (P less than 0.001) in the level of plasma aldosterone. In contrast, captopril-treated dogs showed no change in plasma aldosterone concentration in response to potassium. When angiotensin II was administered to captopril-treated dogs responsiveness to potassium administration was restored (plasma aldosterone concentration increased by 7.4 +/- 2.1 ng/dl, P less than 0.002). ACTH stimulated aldosterone secretion despite captopril treatment (P less than 0.001), however, ACTH produced a greater increase in the plasma aldosterone concentration in controls than in captopril-treated animals. It is evident from these results that stimulation of aldosterone secretion by potassium is considerably enhanced by angiotensin II. There appears to exist an important interdependence of these stimuli in the regulation of aldosterone secretion.
No takes yet. Share an insight, caveat, or question.
J. Howard Pratt (1982) studied Healthy (animal model) (n=34). Captopril vs. Control (no captopril) was evaluated on Increase in plasma aldosterone concentration after potassium infusion (p=< 0.001). Captopril treatment abolished the increase in plasma aldosterone concentration in response to potassium infusion, an effect that was restored by concurrent administration of angiotensin II.
Synapse has enriched 10 related papers. Consider them for comparative context: